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Background: The wide-scale implementation of insecticide-treated nets and indoor residual spraying (IRS) has
contributed to a considerable decrease of malaria morbidity and mortality in sub-Saharan Africa over the last decade.
Due to increasing resistance in Anopheles gambiae sensu lato mosquitoes to dichlorodiphenyl trichloroethane (DDT)
and pyrethroids, alternative insecticide formulations for IRS with long-lasting residual activity are required to sustain the
gains obtained in most malaria-endemic countries.
Methods: Three experimental capsule suspension (CS) formulations of the organophosphate pirimiphos-methyl were
evaluated together with Actellic 50 EC, an emulsifiable concentrate (EC) of pirimiphos-methyl, and the pyrethroid ICON
10 CS, a lambda-cyhalothrin CS formulation, in an experimental hut trial. The formulations were tested on two types of
surfaces: mud and cement. The study with a 12-month follow-up was carried out in Bouaké, central Côte d’Ivoire, where
An. gambiae mosquitoes show high levels of resistance against pyrethroids, DDT and carbamates. Residual activity was
also tested in cone bioassays with the susceptible An. gambiae KISUMU strain.
Results: One of the CS formulations of pirimiphos-methyl, CS BM, outperformed all other formulations tested. On
cement surfaces, the odds ratios of overall insecticidal effect on An. gambiae s.l. of pirimiphos-methyl CS BM compared
to Actellic 50 EC were 1.4 (95% confidence interval (CI): 1.2–1.7) for the first three months, 5.6 (95% CI: 4.4–7.2) for the
second three months, and 3.6 (95% CI: 3.0–4.4) for the last six months of follow-up. On mud surfaces, the respective
odds ratios were 2.5 (95% CI: 1.9–3.3), 3.5 (95% CI: 2.7–4.5), and 1.7 (95% CI: 1.4–2.2). On cement, the residual activity of
pirimiphos-methyl CS BM measured using cone tests was similar to that of lambda-cyhalothrin and for both treatments,
mortality of susceptible Kisumu laboratory strain was not significantly below the World Health Organization pre-set
threshold of 80% for 30 weeks after spraying. Residual activity was shorter on mud surfaces, mortality falling below 80%
on both pirimiphos-methyl CS BM and lambda-cyhalothrin treated surfaces at 25 weeks post-treatment.
Conclusion: CS formulations of pirimiphos-methyl are promising alternatives for IRS, as they demonstrate prolonged
insecticidal effect and residual activity against malaria mosquitoes.
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Long-lasting insecticidal nets (LLINs) and indoor residual
spraying (IRS) are the key interventions of current malaria
vector control [1-3]. While IRS acts mainly by killing
blood-fed mosquitoes that may be infected with the
malaria parasite and thus provides protection to the
wider community, LLINs primarily provide personal
protection but do also show a community effect as they
kill host-seeking mosquitoes. IRS using dichlorodiphe-
nyl trichloroethane (DDT) was the mainstay of the first
global malaria eradication campaign in the 1950s and
1960s [4,5] and is among the World Health Organiza-
tion’s (WHO) recommended insecticides for IRS [6].
However, due to concerns about its safety for the envir-
onment, alternatives are being sought to replace DDT
[7]. Moreover, the spread of resistance to DDT and py-
rethroids across sub-Saharan Africa poses a threat to
insecticide-based vector control interventions [8,9].
Available alternatives to DDT and pyrethroids are formu-
lations of carbamates and organophosphates. However,
these formulations are short-lived. Therefore, new formu-
lations with alternative active ingredients and prolonged
activity are urgently needed. A promising strategy is the
repurposing of existing insecticides not currently used in
public health, together with the development of improved
longer lasting formulations using micro-encapsulation. A
prominent candidate resulting from this strategy is micro-
encapsulated pirimiphos-methyl [10-13].
Here, results from an experimental hut trial that
compared the efficacy and residual activity of a lambda-
cyhalothrin capsule suspension (CS) and four pirimiphos-
methyl formulations, including an emulsifiable concentrate
(EC) and three different CS formulations, are reported. The
study was carried out in central Côte d’Ivoire where
Anopheles mosquitoes show high levels of resistance to
DDT, pyrethroids, and carbamates [14].
Methods
Study site
The study was conducted in central Côte d’Ivoire at the
field station of the Institute Pierre Richet in the M’Bé
valley near Bouaké (geographical coordinates: 7.970241° N
latitude and 5.209963° W longitude). The region is a cli-
matic transition zone with two or four seasons depending
on the year. The dry season is marked by the harmattan,
a dry wind that blows south from the Sahara from the end
of November to the middle of March. The rainy season is
characterized by two rainfall maxima, one in June and an-
other in September. The average annual precipitation is
between 1,000 and 1,320 mm, and was 1,370 mm between
September 2008 and August 2009 when the current study
was implemented. The temperature varies little through-
out the year, with averages of 26 to 28°C. The annual
average relative humidity is between 75 and 90%. Thehydrographic network is dense, consisting of the Bandama
and N’Zi rivers. The M’Bé valley is a rice-growing area
providing suitable breeding sites for anthropophilic mos-
quitoes. The majority of the Anopheles gambiae sensu lato
mosquitoes found in the area are highly resistant to DDT,
pyrethroids and carbamates [14,15]. Insecticide resistance
is likely through metabolic mechanisms and target-site in-
sensitivity (i.e., L1014F kdr) [14].Experimental huts
Twenty-four typical West African-style experimental
huts [6,16] were built. The huts comprised of a sleeping
room, into which wild mosquitoes could enter through
window slits that limited their escape, and a veranda
trap, into which mosquitoes could enter from the sleep-
ing room. For 12 huts, the walls of the room were made
of concrete bricks coated with cement, and for the other
12 huts, the walls were wood structures coated in dry
mud (locally called banco) reflecting local housing con-
struction [17,18]. These two wall types have different
porosity and alkaline characteristics [12,19,20]. The huts
were covered with corrugated iron roofs and the ceiling
consisted of polyethylene sheeting covered by palm
thatch (Figure 1).Insecticide treatments
The insecticide formulations were produced and pro-
vided by Syngenta Crop Protection AG and included
pirimiphos-methyl 50% EC (Actellic 50 EC), pirimiphos-
methyl AA 30% CS, pirimiphos-methyl B 30% CS,
pirimiphos-methyl BM 30% CS, and lambda-cyhalothrin
10% CS (ICON 10 CS). The formulations of pirimiphos-
methyl differed in the type of solvent used to dissolve the
active ingredient and in the cross-linking of the polymer
capsule.
All pirimiphos-methyl treatments were applied at a
target application rate of 1 g/m2. Lambda-cyhalothrin
CS, included as a positive control, was applied at a target
application rate of 0.025 g/m2, according to the WHO
Pesticide Evaluation Scheme (WHOPES) recommenda-
tions [21]. For each treatment arm (formulation com-
bined with either mud or cement wall surface), two huts
were sprayed. An additional four huts (two mud and two
cement walled huts) served as negative controls, making
a total of 24 huts.
The huts were randomly allocated to insecticide treat-
ments and their wall surfaces and palm thatch ceilings
sprayed at an application rate of 35 ml/m2 with an aque-
ous solution of the aforementioned insecticides using
a Hudson X-pert compression sprayer (HD Hudson
Manufacturing Company; Chicago, USA) without a con-
trol valve. Spraying was carried out by a single, trained
male sprayer in September 2008.
Figure 1 Experimental huts used in the study located in the M’Bé site, near Bouaké in central Côte d’Ivoire. The experimental huts
comprised a sleeping room and a veranda. The walls of the room were either made of concrete bricks coated with cement (a) or wood
structures coated in dry mud – locally called banco (b).
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The experimental procedure followed WHOPES guidelines
for testing mosquito adulticides for IRS and treatment
of mosquito nets [21]. On trapping nights, adult male
sleepers identified from the communities entered the
experimental huts at 18:00 hours and remained inside
until 06:00 hours the next morning. The sleepers were
rotated between huts on subsequent trapping nights.
Trapping nights were scheduled on nights 1, 3, 5, 8, 10,
12, 15 and so on following this pattern. The follow-up
duration was 12 months.
In order to measure the insecticidal efficacy of the IRS
treatments, every morning at 06:00 hours, mosquitoes
were collected from the rooms and the verandas and trans-
ferred to an insectary in Bouaké where the mosquitoes werescored as either dead or alive, and blood fed or unfed. Sur-
vivors were placed in small plastic cups and provided with
10% honey solution, and mortality was recorded after a
24-hour holding period.
All mosquitoes caught were identified to genus (and
where possible to species) level using readily available mor-
phological identification keys [22]. A subsample of speci-
mens identified as An. gambiae s.l. was further determined
using the diagnostic polymerase chain reaction (PCR) de-
veloped by Santolamezza and colleagues [23]. Template
deoxyribonucleic acid (DNA) was extracted from speci-
mens dried over silica gel following the Livak protocol
[24]. Sleepers and investigators who analysed the mosqui-
toes in the laboratory were blinded to the identity of the
treatment used in each hut, minimizing potential biases.
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In June 2009, field collected anopheline larvae were
reared to adults, and An. gambiae s.l. were exposed for
one hour to 4% DDT, 0.75% permethrin and 0.05% del-
tamethrin in WHO susceptibility tests [21].
Residual activity
The residual activity of the IRS treatments was moni-
tored on weeks 1, 5, 10, 15, 20, 25, 30, 35, 39, 42, 45,
and 49 post-treatment using WHO plastic cones placed
on treated surfaces, exposing female mosquitoes for
30 min and recording 24-hour mortality, according to
WHOPES guidelines [21]. Replicate arms were tested on
alternate testing rounds: e.g., one cement hut with Actel-
lic 50 EC was tested on weeks 1, 10, 20, 30, 39 and 45
and the other cement hut with Actellic 50 EC was tested
on weeks 5, 15, 25, 35, 42 and 49. Assays were run using
susceptible KISUMU An. gambiae sensu stricto mosqui-
toes. In the insectary, the larvae were fed with Mikromin
fish food (Tetra; Melle, Germany) and reared to im-
agines and used in the tests two to five days post eclo-
sure from the pupae.
Sleepers’ perception of insecticide formulations
Sleepers were interviewed by social scientists using a
pre-tested questionnaire about their perception of in-
secticide formulations, characteristics of the odour and
whether the product had an influence on their sleep
quality. Questionnaires were filled in twice daily, once
before sleepers entered the hut and then again the next
morning after mosquito collection was completed.
Ethical considerations
This study received ethical approval from the Ministry of
Health in Côte d’Ivoire through the national malaria con-
trol programme. At the study start, the national ethics
committee for research in Côte d’Ivoire was not yet func-
tional. The study was approved by the institutional review
boards. As most sleepers were illiterate, informed consent
was received orally. Prior to enrolment in the study, it was
ensured that all sleepers were vaccinated against yellow
fever. Sleepers were medically supervised throughout the
study and six months after. Suspected malaria episodes
(e.g., fever and headache) were treated with an artesunate-
amodiaquine combination. The young adult male sleepers
were identified in the community and they received a
small financial compensation for their participation. They
had the right to withdraw from the study at any time with-
out further obligations.
Statistical analysis
Data were double-entered and cross-checked using
EpiInfo version 6.4 (Centers for Disease Control and
Prevention; Atlanta, USA). The mosquito data from theexperimental huts were summarized per treatment arm
in terms of crude rates of standard primary outcomes
(crude hut entry rate, crude exit rate, crude feeding rate
and crude mortality rate) for three time periods: period
1: first three months, corresponding to 40 trapping
nights; period 2: second three months, corresponding to
39 trapping nights; and period 3: last six months, corre-
sponding to 77 trapping nights.
A series of Bayesian statistical models was used to esti-
mate the effect of the insecticide formulations on deter-
rence from hut entry, induced exophily, feeding inhibition,
killing efficacy, personal protection, and overall insecti-
cidal effect [25]. This was done separately for each formu-
lation, wall type, and time period. Details of the definitions
of these efficacy measures and how they were calculated
are given in Additional file 1. The Bayesian approach dir-
ectly provided both point and interval estimates of the
insecticide efficacy measures over time, appropriately
allowing for day-to-day fluctuations in mosquito density
and background mortality in controls. Since it is reason-
able to presume that the insecticides’ efficacies decay over
time (see Additional file 2), and that the size of the host-
seeking mosquito populations fluctuates strongly over the
year (see Additional file 3), failure to allow for day-to-day
variation in the mosquito population could potentially
lead to strong biases (e.g., if the mosquito density peaked
towards the end of the period of interest, due to the
decayed insecticide, this would underestimate the efficacy
estimate for that period). Prior distributions were defined
that constrained these estimates to be between zero and
unity and comparison between parameters was made by
comparing the 95% credible intervals. A lack of overlap in
credible intervals indicates that the differences between
the effects of the insecticide formulations are unlikely to
be due to chance. Summaries of experimental hut data,
crude analysis and Bayesian analysis are provided as sup-
plementary information (see Additional files 1, 2, 3 and 4).
Descriptive statistics, Bayesian statistical models, and
graphs were generated in the statistical software R version
2.14.1 [26].Results
Mosquito species and abundance
From September 2008 to August 2009, a total of 77,948
mosquitoes were collected during 7,488 man-night
catches by the young adult sleepers across all 24 experi-
mental huts (Table 1). Anopheles gambiae s.l. was the
predominant mosquito taxon (63.9%). Molecular analysis
showed that from 120 analysed An. gambiae s.l. specimens
89% were An. gambiae s.s. The remaining An. gambiae s.l.
specimens were Anopheles coluzzii (11%). Other anophel-
ine species collected were Anopheles funestus (2.7%) and
other not further identified Anopheles species (3.3%). The
Table 1 Number of mosquitoes collected, stratified by taxa and treatment arm over the 12-month study period
(September 2008 to August 2009) in experimental huts at the M’Bé station, near Bouaké in central Côte d’Ivoire
Species Untreated
(negative control)
Lambda-cyhalothrin
ICON 10 CS
(positive control)
Pirimiphos-methyl Total (%)
Actellic 50 EC CS AA CS B CS BM
Cement Mud Cement Mud Cement Mud Cement Mud Cement Mud Cement Mud
An. gambiae s.l. 4,775 5,737 4,969 5,941 3,035 3,601 2,826 4,446 2,407 3,871 3,889 4,278 49,775 (63.9%)
An. funestus 324 300 132 170 116 145 100 223 78 170 114 204 2,076 (2.7%)
Other Anopheles 177 415 238 215 159 257 188 228 103 180 222 204 2,586 (3.3%)
Other genera
(Mansonia,
Culex, Aedes)
1,628 3,869 959 1,183 1,697 2,297 1,229 2,288 1,276 2,546 1,672 2,867 23,511 (30.2%)
Total 6,904 10,321 6,298 7,509 5,007 6,300 4,343 7,185 3,864 6,767 5,897 7,553 77,948
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africana, Mansonia uniformis, Culex spp., or Aedes spp.
Effects of insecticides on mosquitoes
Crude rates of standard primary outcomes for both huts
per treatment arm pooled are depicted graphically in
Figure 2. The entry rates (Figure 2a), the proportion
that exited (Figure 2b), the proportion found to be
fed (Figure 2c), and the proportion killed (Figure
2d) all varied considerably between time periods.
Crude rates per hut are depicted graphically as supple-
mentary information in Additional files 5, 6, 7, and 8
for An. gambiae s.l., An. funestus, other anophelines and
other genera, respectively. Of the primary outcomes, the
entry rate showed the most variation between huts of the
same treatment arm.
Effects of insecticide expressed in derived summary
measures (deterrence from hut entering, induced exophily,
blood feeding inhibition, killing, personal protection and
insecticidal effect) on An. gambiae s.l. are shown in Figure 3.
For An. funestus and other Anopheles, similar figures are
available in Additional files 9 and 10, respectively.
The deterrent effects of lambda-cyhalothrin and
pirimiphos-methyl on hut entry of An. gambiae s.l. are
shown in Figure 3a. Whereas lambda-cyhalothrin deter-
rence was very low and often not significantly different
from zero, deterrence was much higher with pirimiphos-
methyl, preventing up to 60% of An. gambiae s.l. mosqui-
toes from entering the huts.
Induced exophily showed an inverse relationship with
insecticide type as compared to deterrence. Lambda-
cyhalothrin induced up to 60% of mosquitoes that entered
to exit. In contrast, induced exophily with pirimiphos-
methyl was very low and often not significantly different
from zero (Figure 3b).
Neither pirimiphos-methyl nor lambda-cyhalothrin pre-
vented many of the mosquitoes that entered from feed-
ing. Lambda-cyhalothrin prevented 5–21% of entered
An. gambiae s.l. from feeding almost consistently during
the year, whereas pirimiphos-methyl only prevented12% of entered An. gambiae s.l. from feeding in the fisrt
three months (Figure 3c). However, pirimiphos-methyl
showed the strongest lethal effects, with killing of entered
An. gambiae s.l. being approximately double that of
lambda-cyhalothrin (Figure 3d).
The killing effect in cement huts sprayed with
pirimiphos-methyl CS BM was above the WHO pre-set
threshold of 80% for the first three months (92%, 95%
confidence interval (CI): 90–94%), was above 70% for
the second three month period (74%, 95% CI: 71–77%),
and above 50% for the last six months (55%, 95% CI:
52–57%). In mud huts, the killing effect of pirimiphos-
methyl CS BM was about 50% during the first three
months (51%, 95% CI: 47–55%) and about half of
that during the second three month period (27%, 95%
CI: 24–30%). In contrast, the killing effect was much
lower for lambda-cyhalothrin, being 58% (95% CI: 55–61%),
26% (95% CI: 21–30%) and 15% (95% CI: 13–17%) in ce-
ment huts during periods 1, 2, and 3 respectively. Simi-
larly, the effect was lower in mud huts sprayed with
lambda-cyhalothrin. Overall, the decline in killing effect
was faster in mud huts compared to cement huts, and
varied between the different products, with pirimiphos-
methyl formulations CS B and CS BM having the highest
effect for the longest period in both hut types.
Results for personal protection against An. gambiae
s.s. bites were variable. For example, during period 1
and period 3, personal protection was greater for
pirimiphos-methyl formulation CS BM than for
lambda-cyhalothrin (Figure 3e), but it was inverse
during period 2.
The overall insecticidal effect of CS formulations of
pirimiphos-methyl on cement walls was relatively stable
over time compared to on mud walls, where the effect
was stronger during the first period but dropped faster
in the two following periods (Figure 3f ). On cement, the
insecticidal effect of pirimiphos-methyl EC and of
lambda-cyhalothrin dropped faster between the first and
second three-month periods compared to the drop in ef-
fect of pirimiphos-methyl CS. On mud, the insecticidal
Figure 2 Crude results from experimental hut trials of pirimiphos-methyl and lambda-cyhalothrin on Anopheles gambiae s.l. Entry rate,
number of mosquitoes per hut per night; exit rate, proportion of mosquitoes found in the veranda trap out of mosquitoes that entered; feeding
rate, proportion of mosquitoes that were blood fed out of mosquitoes that entered; mortality rate, proportion of mosquitoes that were found
dead or died after 24 hours post-collection out of mosquitoes that entered. The first horizontal axis labels refer to the period after spraying, with
period 1 (months 1–3, corresponding to 40 trapping nights), period 2 (months 4–6, corresponding to 39 trapping nights), and period 3 (months
7–12, corresponding to 77 trapping nights). The second horizontal axis labels refer to the material of the walls of the huts where ‘brick’ refers to
walls from concrete bricks coated with cement and where banco refers to wood structures coated in dry mud. The third (bottom) horizontal axis
labels refer to experiment arms: a control, a lambda cyhalothrin (ICON 10 CS) and four different formulations of pirimiphos-methyl (Actellic 50 EC,
CS AA, CS B, and CS BM).
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fast.
Figure 4 provides a visualization of the overall insecti-
cidal effect on An. gambiae s.l. of pirimiphos-methyl for-
mulations relative to lambda-cyhalothrin. For the overall
insecticidal effect on An. gambiae s.l., with the exception
of CS BM, pirimiphos-methyl was significantly inferior
to lambda-cyhalothrin during the first three months on
cement surfaces (Figure 4). However, on mud surfaces,
pirimiphos-methyl was significantly superior to lambda-
cyhalothrin. For the other periods of follow-up on ce-
ment, the overall insecticidal effect of Actellic 50 EC was
not significantly different from the effect of lambda-
cyhalothrin. However, on mud surfaces, it did outperform
lambda-cyhalothrin (Figure 4). For the second trimesterand last six months, all CS formulations of pirimiphos-
methyl outperformed lambda-cyhalothrin (Figure 4). When
ranking the different formulations the order is: Actellic 50
EC (least good), CS AA, CS B, and CS BM (best). The
highest odds ratio relative to lambda-cyhalothrin was esti-
mated for CS BM on mud for the second three-month
period after application, with an odds ratio of 18.4 (95%
CI: 10.6–48.4). For An. funestus and other Anopheles,
similar figures are available in Additional files 11 and 12,
respectively.
Figure 5 provides a comparison of the overall insecti-
cidal effect on An. gambiae s.l. of the CS formulations of
pirimiphos-methyl compared to the EC formulation of
pirimiphos-methyl. During the first three months on ce-
ment surfaces, formulations of CS AA and CS B were
Figure 3 Summary measures of the effects of pirimiphos-methyl and lambda-cyhalothrin on Anopheles gambiae s.l. Summary measures
are a deterrence from hut entry (see Additional file 1); b induced exophily (denoted ‘repellence’ in Additional file 1); c feeding inhibition (see
Additional file 1); d killing effect (see Additional file 1); e personal protection, which combines effects of feeding inhibition and deterrence from
hut entry [25]; and f overall insecticidal effect, which combines killing effect and deterrence from hut entry, adjusting for killing in control huts
[25]. Points indicated posterior means and error bars indicate 95% credible intervals. The first horizontal axis labels refer to the period after
spraying, with period 1 (months 1–3, corresponding to 40 trapping nights), period 2 (months 4–6, corresponding to 39 trapping nights), and
period 3 (months 7–12, corresponding to 77 trapping nights). The second horizontal axis labels refer to the material of the walls of the huts
where ‘brick’ refers to walls from concrete bricks coated with cement and where banco refers to wood structures coated in dry mud. The third
(bottom) horizontal axis labels refer to the insecticide and formulation: a lambda-cyhalothrin (ICON_10CS), and four different formulations of
pirimiphos-methyl (Actellic 50 EC, CS AA, CS B, and CS BM).
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tios being slightly but significantly below one. For the
first three months and also for the last six months, on
mud surfaces, the median odds ratio for CS AA washigher than one but this was not significant as the 95%
CI included one. For all other comparisons, the odds ra-
tios for CS formulations were significantly higher than
one. Formulation CS BM had generally the highest odds
Figure 4 Odds ratio of overall insecticidal effect of pirimiphos-methyl relative to lambda-cyhalothrin on Anopheles gambiae s.l. Points
indicate posterior means and error bars indicate 95% credible intervals. The first horizontal axis labels refer to the four different formulations of
pirimiphos-methyl (Actellic 50 EC, CS AA, CS B and CS BM). The second horizontal axis labels refer to the material of the walls of the huts where
‘brick’ refers to walls from concrete bricks coated with cement and where banco refers to wood structures coated in dry mud. The third (bottom)
horizontal axis labels refer to the period after spraying, with period 1 (months 1–3, corresponding to 40 trapping nights), period 2 (months 4–6,
corresponding to 39 trapping nights), and period 3 (months 7–12, corresponding to 77 trapping nights).
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where formulation CS B was somewhat higher.
Insecticide susceptibility status
The results of the WHO susceptibility test experiment
are given in Table 2. Twenty-four hours post-exposure,
mortality was 0, 4.5, 10.6 and 44.6% in control, DDT,
permethrin and deltamethrin arms, respectively.
Residual activity
Residual activity of the insecticide formulations against
the susceptible KISUMU strain, as measured by the WHO
cone bioassays, did not vary much with surface, with 95%
CIs mostly overlapping for matching test rounds and in-
secticide formulations (Figure 6). However, the residual
activity was longer on cement surfaces. The observed
mortality of KISUMU on cement surfaces treated with
lambda-cyhalothrin or the CS BM formulation of pirimiphos-
methyl was not significantly below the WHO 80% thresholdfor the first 30 weeks after application. For pirimiphos-methyl
CS AA and CS B, this was for the first 20 weeks, and for
Actellic 50 EC this was 10 weeks. On mud surfaces, the
residual effect was shorter: for pirimiphos-methyl CS BM
and lambda-cyhalothrin, mortality was not significantly
below 80% for the first 20 weeks. For mud surfaces treated
with CS AA, CS B, and EC formulations of pirimiphos-
methyl, mortality was significantly below 80% 15 weeks
after application.
Sleepers’ perception of insecticide formulations
Differences were found in the perceived strength and
odour of the insecticides according to the formulations
of pirimiphos-methyl and depending on the wall type of
the experimental huts (see Additional file 13). On huts
constructed from cement bricks, formulations CS B and
CS AA were considered the least dangerous, but some-
what less efficient and had an odour which was less
pleasant. On mud walled huts, formulation CS BM was
Figure 5 Odds ratio of overall insecticidal effect of pirimiphos-methyl CS and lambda-cyhalothrin relative to pirimiphos-methyl EC
(Actellic 50 EC) on Anopheles gambiae s.l. Points indicate posterior means and error bars indicate 95% credible intervals. The first horizontal
axis labels refer to the three different CS formulations of pirimiphos-methyl (CS AA, CS B and CS BM) and lambda-cyhalothrin (ICON 10 CS).
Legend further as in Figure 4.
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but was perceived somewhat more dangerous than the
other products.
Discussion
Currently four classes of insecticides targeting adult
mosquitoes are endorsed by WHO for use in IRS: pyre-
throids, organochlorines, carbamates and organophos-
phates [6]. Pyrethroids exhibit low mammalian toxicity
in their application and a rapid knock-down effect [27]Table 2 Knock down and mortality of wild An. gambiae
s.l. in WHO susceptibility tests
Treatment Knocked down (%) Mortality (%) n
Control 0 0 50
DDT 4% 3.0 4.5 132
Deltamethrin 0.05% 56.1 44.6 139
Permethrin 0.75% 0.6 10.6 160
Legend: n = number tested.and the formulations for IRS are relatively long-lasting
(at least three months) [28]. DDT, the only available or-
ganochlorine for IRS, shows rapid knock-down effect and
relative longevity but due to resistance and environmental
concerns, its use in vector control programmes is declin-
ing as alternative insecticides with better target product
profiles are becoming available [28,29]. Bendiocarb, repre-
senting the carbamates, is also used for IRS, is highly ef-
fective and shows little excito-repellency. Yet, bendiocarb
has a short residual life and is not a favourable option in
areas of long or perennial malaria transmission as multiple
applications would be required to cover the whole season.
The last class is that of the organophosphates to which
pirimiphos-methyl belongs. The organophosphates are
similar to the carbamates in their mode of action and are
generally also rather short-lived (as found for Actellic
50 EC in this study). While bendiocarb (a carbamate) and
organophosphates have the downside of showing a short
residual life, they may become viable alternatives in
areas with a short transmission season as resistance to
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Figure 6 Residual activity of insecticide formulations against susceptible Anopheles gambiae. Mortality in WHO cone tests after 24 hours
of An. gambiae of the KISUMU strain a on cement surfaces, and b on mud surfaces. Error bars show 95% confidence intervals. The red dotted line
shows the WHO threshold of 80%. The first horizontal axis labels refer to the week of testing post-treatment.
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http://www.malariajournal.com/content/13/1/332pyrethroids – and cross-resistance to DDT – becomes
widespread in Anopheles populations threatening the sus-
tenance of gains made in the control of malaria with
pyrethroid-based LLINs and IRS [9]. Micro-encapsulation
of pirimiphos-methyl makes this active ingredient an alter-
native in areas with pyrethroid resistance where the mal-
aria transmission season is long.
On cement walls, residual activity of both lambda-
cyhalothrin and pirimiphos-methyl CS lasted for up to30 weeks as compared to 10 weeks with the EC formu-
lation, corroborating recent observations in Tanzania
[10,12]. On mud walls, however, residual activity of both
lambda-cyhalothrin and pirimiphos-methyl was shorter,
suggesting a strong influence of the substrate to which it
is applied. It has been documented before that the persist-
ence of an insecticide depends on a number of factors, in-
cluding the type of the surface and formulation type. On
traditional mud walls, the approximate duration of the
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(i.e., malathion and fenitrothion) is three monthsa and of
DDT is six months [30]. Malathion sprayed on wood may
last more than three months, whereas on some mud sur-
faces it may last for only three weeks [30]. Mud surfaces
generally absorb some of the applied insecticide and cer-
tain types of mud may also break down insecticides chem-
ically [19,20].
Towards the end of the experimental hut trial, in June
2009, wild mosquitoes in M’Bé showed 10.6 and 44.6%
mortality with 0.75% permethrin and 0.05% deltamethrin,
respectively. No contemporary data on mortality with
lambda-cyhalothrin and pirimiphos-methyl are available
but permethrin deltamethrin and lambda-cyhalothrin
are all pyrethroids, so cross-resistance may be roughly
comparable. For instance, in Yaokoffikro, 35 km south of
M’Bé, in June 2008, Koffi and colleagues [31] observed
69% and 68% mortality with 1% permethrin and 0.05%
lambda-cyhalothrin, respectively. If cross-resistance in
M’Bé is similar, a mortality of about 10.6% could be
expected with 0.05% lambda-cyhalothrin. However, in
M’Bé, in May 2012, Koffi and colleagues [14] observed
51.2%, 75.8% and 98.1% mortality with 0.75% permethrin,
0.05% deltamethrin and 1% pirimiphos-methyl, respec-
tively. As the mortality was higher with pyrethroids in
2012 than observed in 2009, it is possible that the M’Bé
An. gambiae population had lost some pyrethroid resis-
tance. Since exposure of the M’Bé An. gambiae population
to pirimiphos-methyl prior to this study was probably low
and measured susceptibility in 2012 was high, the An.
gambiae population in 2009 was probably fully susceptible to
this insecticide. Potentially lower pyrethroid resistance in
Yaokoffikro (68.9% mortality in 2008 with 1% permethrin),
compared with M’Bé (10.6% and 51.2% mortality with
0.75% permethrin in 2009 and 2012, respectively) may
explain why activity of lambda-cyhalothrin was comparable
to that of pirimiphos-methyl when tested in cone tests with
An. gambiae from Yaokoffikro (see Additional file 14).
The experimental hut results on mortality with free
flying An. gambiae s.l. were consistent with the results
from cone tests for residual activity: both effects on mor-
tality and residual activity lasted longer on cement than
on mud, and longer for pirimiphos-methyl CS BM than
for Actellic 50 EC. Indeed, the lower effects on mortality
of free flying An. gambiae s.l. of lambda-cyhalothrin,
despite its persistent activity, can be attributed to
pyrethroid resistance.
The positive control (lambda-cyhalothrin) also showed
greater insecticidal effects on cement than on mud huts,
but it killed a much lower proportion of the mosquitoes
that had entered the huts than did pirimiphos-methyl,
with a substantial proportion of mosquitoes diverted
into the veranda. Surviving unfed mosquitoes were found
in pyrethroid-treated huts, indicating that pyrethroidinhibited feeding. Such mosquitoes were infrequent in
pirimiphos-methyl treated huts, where mosquitoes had
high blood-feeding rates, which is in agreement with results
from experimental hut trials where pirimiphos-methyl was
applied to bed nets [32].
The numbers of mosquitoes entering the pirimiphos-
methyl-treated huts were lower than with either control
or pyrethroid-treated huts, suggesting that the latter de-
terred mosquitoes from entering. This apparent deter-
rence was the main driver of the estimated high personal
protection effects of the insecticide. In general, organo-
phosphate insecticides are considered to be non-irritant
[33], so the observation of deterrency is somewhat sur-
prising, given the low level of excito-repellency observed
with pirimiphos-methyl [10] but consistent with hut stu-
dies in Benin [34]. Perhaps the design of the experimental
hut may explain some of the observed variation.
As blank collections immediately prior to the study
suggested little bias between huts, each treatment was
randomly assigned to two huts, and data from the two
huts that received the same treatment were pooled for
all subsequent analyses. However, there was considerable
variation between huts in numbers of mosquitoes ente-
ring (see Additional files 5, 6, 7 and 8), presumably
because house entering depended on the locations of the
huts relative to breeding sites and on external environ-
mental features affecting mosquito movement. It would
be recommendable for future hut trials to include more
replications per arm, or to rotate sprayed panels, in
order to reduce any bias in deterrence (from hut entry)
estimates due to hut location. In contrast, the hut loca-
tion did not appear to have had a notable effect on
estimates of feeding inhibition, killing, or repellency, for
which variations between huts were reduced by stan-
dardizing hut design.
The survival of mosquitoes in control huts showed
temporal variation, making it essential to allow for a
temporal dimension in the analysis of the insecticidal
efficacy (defined as the proportion of mosquitoes killed
among those that would have survived in negative con-
trol huts). The temporal fluctuations in mortality rates
were also observed in the control bioassays and might
be explained by the desiccating effects of the harmattan.
An alternative to the Bayesian approach applied in the
current study would have been to use generalized linear
mixed model (GLMM) approaches to calculate mortality
and feeding, with only crude adjustment for temporal
variations in mosquito densities and insecticidal effects.
This would have required plug-in estimates from the
GLMMs into the formulae for the insecticide efficacy
measures, leading to potentially biased estimates and CIs
based on complex approximations.
Recent studies have shown that IRS applications might
lack precision, calling for standardized testing guidelines
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posed and sent overseas for the analysis of the insecticide
dose. Unfortunately, due to substantial delays, accurate
readings could not be obtained. Therefore, no confirm-
ation is available that the specified insecticide target doses
were obtained. Despite adhering to WHOPES guidelines
and standard protocols with the spraying, these results
must be interpreted with some care. However, products
were diluted according to recommendations and as all
the applications were made by a single operator, one
could assume that any errors would be similar across
treatments.
The effect of IRS on malaria transmission is primarily
measured by its overall insecticidal effect [25]. In the
present analyses, the overall insecticidal effect was com-
puted conservatively assuming that neither deterrence nor
repellency affects mosquito viability. Overall, taking into
account estimated deterrency, repellency, blood-feeding
rates and killing effects, pirimiphos-methyl provided both
greater personal protection and a larger overall insecticidal
effect against An. gambiae s.l. than did the pyrethroid con-
trol, on both tested surfaces.
Conclusions
CS formulations of pirimiphos-methyl showed higher effi-
cacy against pyrethroid-resistant Anopheles mosquitoes
than lambda-cyhalothrin CS and extended life span com-
pared to the EC formulation. The results presented here
stemming from a large experimental hut trial conducted
in an area of Côte d’Ivoire where malaria vectors are re-
sistant against pyrethroids [14] confirm that pirimiphos-
methyl CS is a valuable alternative IRS insecticide [12,33].
Hence, pirimiphos-methyl CS might be considered to
replace pyrethroids in areas where resistance to the latter
class of insecticides is widespread or developing, which in
turn might slow the development of pyrethroid resistance.
Endnote
aA more recent WHO publication [36] gives duration
ranges for malathion of 2–3 months, and for fenitrothion
of 3–6 months, stating “It should be noted that the re-
sidual effect of insecticides can be much shorter on
some surfaces, such as porous mud walls, walls covered
by cement or alkaline whitewash and surfaces exposed
to sunlight”.
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